Last reviewed · How we verify

NCT06699927

Working Memory Training for People Aging with HIV

Recruiting now EARLY_PHASE1 Last updated 26 November 2024
What this trial tests

EARLY_PHASE1 trial testing Span in Cognitive Change in 80 participants. Currently enrolling.

Timeline
15 July 2024
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorNortheastern University
PhaseEARLY_PHASE1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposebasic science
Enrollment80
Start date15 July 2024
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northeastern University

Who can join

Adults 50 to 85, any sex, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study investigates the feasibility of working memory training in people aging with HIV (PAWHIV). In a cross-over design this stage 1 feasibility trial, will evaluate acceptability, and estimate possible effect sizes related to working memory training by examining potential differential effects in PAWHIV and those aging without HIV. This project highlights the importance of tailored cognitive assessments and interventions, engaging with underrepresented communities to enhance inclusivity in cognitive health research.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Span

Trials testing the same drug.

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

Other Northeastern University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06699927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing